Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ Rat GM-CSF ELISA Test Kit

Product Description
The MaxDiscovery™ Rat GM-CSF ELISA Test Kit is designed for quantitative determination of the concentration of rat GM-CSF in serum, plasma, and cell culture supernatant. Rat mature granulocyte macrophage colony stimulating factor (GM-CSF) is a polypeptide of 127 amino acids with one potential N-linked glycosylation site and two intramolecular disulfide bonds. Natural rat GM-CSF is a monomeric glycoprotein with an apparent molecular mass ranging from 27 - 44 kDa. Rat GM-CSF shares 69% and 62% amino acid sequence identity with mouse and human GM-CSF, respectively. While rat and mouse GM-CSF have reciprocal cross-species activity, they are not active on human cells. GM-CSF is produced by a number of type II alveolar cells, renal mesangial cells, and endothelial cells. It is a pleiotrophic cytokine that stimulates the proliferation, differentiation, migration and survival of hematopoietic progenitor cells of the neutrophil, eosinophil, macrophage, megakaryocyte and erythroid lineages. GM-CSF activates the effector functions of mature neutrophils, eosinophils and macrophages. In concert with IL-4 and other cytokines, GM-CSF induces dendritic cell formation and stimulates their ability to present antigens to cells of the immune system. In addition, GM-CSF inhibits Langerhans cell IL-12 production, thus promoting a generalized Th2-type response. Rat GM-CSF shares 69% and 62% amino acid sequence identity with mouse and human GM-CSF, respectively. While rat and mouse GM-CSFs have reciprocal cross-species activity, they are not active on human cells. Normal mouse and rat sera GM-CSF is undetectable (less than 15.6 pg/mL) in the absence of underlying pathology. In mice and humans, the high-affinity receptor for GM-CSF is composed of a 50 kDa ligand binding alpha subunit (GMR) and a 120 kDa signal transducing beta subunit. Furthermore, syndecan-2 is also reported to be a co-receptor for GM-CSF.
Product MaxDiscovery™ Rat GM-CSF ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2201-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Sanger Institute, St Jude Data-Sharing Agreement
Childhood cancer targeted by Sanger Institute and St Jude Children’s Research Hospital exchanges of cancer data
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!